Medexus Pharmaceuticals holds annual shareholder meeting

Bitget2026/09/24 21:31

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Medexus Pharmaceuticals held its virtual annual shareholder meeting on Sept. 24, 2026.
Shareholders backed the appointment of PricewaterhouseCoopers LLP as auditor.
Votes also adopted amendments to the equity incentive compensation plan.
Director nominees listed in the Aug. 10, 2026 circular were elected to serve until the next annual meeting.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medexus Pharmaceuticals Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202609241730NEWSFILECNPR____20260924_315965_1) on September 24, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Broadcom is leading a $60 billion debt financing initiative to provide funding for AI companies such as Anthropic to purchase chips and build data centers. Of this amount, $42 billion in senior secured bonds will be syndicated by Broadcom with Wall Street banks, while $18 billion in subordinated debt is being led by Blackstone, whose funds have committed $9 billion. The deal has been in preparation for several weeks but has not yet been officially announced.

华尔街见闻•2026/10/02 10:16